• LAST PRICE
    2.8600
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-2.0548%)
  • Bid / Lots
    2.8600/ 1
  • Ask / Lots
    3.1800/ 2
  • Open / Previous Close
    2.8900 / 2.9200
  • Day Range
    Low 2.8100
    High 2.9800
  • 52 Week Range
    Low 2.7000
    High 43.0000
  • Volume
    20,670
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.92
TimeVolumeCYTO
09:32 ET5382.91
09:35 ET18502.9336
09:37 ET11382.91
09:42 ET3002.9298
09:50 ET31872.88
09:57 ET5002.81
10:00 ET2002.843
10:06 ET1002.8555
10:08 ET5002.85
10:11 ET4002.861
10:33 ET1002.86
10:49 ET3482.8741
11:20 ET2842.855
11:27 ET12002.855
12:01 ET20002.88
12:42 ET3002.88
01:00 ET1252.88
01:11 ET1402.88
01:13 ET7142.8606
01:31 ET7572.88
02:34 ET1252.87
02:43 ET2002.9
02:45 ET2002.9299
02:48 ET1042.86
03:03 ET20152.8601
04:00 ET4002.86
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCYTO
Altamira Therapeutics Ltd
3.4M
-0.1x
---
United StatesTENX
Tenax Therapeutics Inc
3.7M
-3.1x
---
United StatesPALI
Palisade Bio Inc
3.7M
-0.1x
---
United StatesDRMA
Dermata Therapeutics Inc
3.7M
-0.2x
---
United StatesVLON
Vallon Pharmaceuticals Inc
3.6M
-0.3x
---
United StatesENDV
Endonovo Therapeutics Inc
3.2M
-0.9x
---
As of 2023-02-07

Company Information

Auris Medical Holding AG is a Switzerland-based biotechnologyompany focused on developing and commercializing therapeutics and medical devices for neurotology, rhinology and allergy and central nervous system (CNS) disorders.The Company is active in active in three areas such as: the development of oligonucleotides for extrahepatic therapeutic targets - OligoPhore platform; nasal sprays for protection against airborne viruses and allergens Bentrio or the treatment of vertigo AM-125 ; he development of therapeutics for intratympanic treatment of tinnitus Keyzilen or hearing loss Sonsuvi .

Contact Information

Headquarters
Clarendon House, 2 Church StreetHAMILTON, ZUG, Bermuda 6300
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.4M
Revenue (TTM)
$1.4M
Shares Outstanding
1.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.40
EPS
$-26.48
Book Value
$18.29
P/E Ratio
-0.1x
Price/Sales (TTM)
2.5
Price/Cash Flow (TTM)
---
Operating Margin
-1,408.64%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.